{"id":19384,"date":"2026-02-20T12:35:12","date_gmt":"2026-02-20T12:35:12","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/19384\/"},"modified":"2026-02-20T12:35:12","modified_gmt":"2026-02-20T12:35:12","slug":"novo-nordisk-nominates-jan-van-de-winkel-and-ramona","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/19384\/","title":{"rendered":"Novo Nordisk nominates Jan van de Winkel and Ramona"},"content":{"rendered":"<p>Editorial &amp; Advertiser disclosure<\/p>\n<p class=\"px-4 py-2 border border-gray-200 mt-2\">Global Banking &amp; Finance Review\u00ae is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.<\/p>\n<p class=\"border-b-[.1rem] pb-1\">Published by Global Banking &amp; Finance Review\u00ae<\/p>\n<p>Posted on February 20, 2026<\/p>\n<p>1 min read<\/p>\n<p class=\"text-sm text-gray-500 italic\">Last updated: February 20, 2026<\/p>\n<p><img alt=\"Novo Nordisk nominates Jan van de Winkel and Ramona Sequeira to board - Finance news and analysis from Global Banking &amp; Finance Review\" data-original=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/02\/1771590912_756_w1280.jpeg\" data-seo-image=\"true\" fetchpriority=\"high\" loading=\"eager\" width=\"1200\" height=\"800\" decoding=\"async\" data-nimg=\"1\" class=\"w-full h-auto object-contain md:object-cover\" style=\"color:transparent;aspect-ratio:auto\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/02\/1771590912_756_w1280.jpeg\"\/><\/p>\n<p>COPENHAGEN, Feb 20 (Reuters) &#8211; Novo Nordisk said on Friday it would nominate\u00a0Jan van de Winkel and Ramona Sequeira to its board of directors, the first additions since a shake-up at the Danish obesity drugmaker last year.<\/p>\n<p>Novo Nordisk and its majority shareholder, the Novo Nordisk Foundation, in 2025 replaced the drugmaker&#8217;s CEO and overhauled the board, installing Lars Rebien Sorensen who also chairs the Foundation, as board chairman, giving him a powerful dual role.<\/p>\n<p>Jan van de Winkel, co-founder and CEO of Genmab, was proposed for election at the annual general meeting to be held on March 26, the Wegovy-maker said in a statement.<\/p>\n<p>Ramona Sequeira acted as President of the Global Portfolio Division of Takeda Pharmaceutical Company Limited from 2022-2025, Novo Nordisk said.<\/p>\n<p> (Reporting by Stine Jacobsen and Louise Rasmussen, editing by Terje Solsvik and Mark Potter)<\/p>\n","protected":false},"excerpt":{"rendered":"Editorial &amp; Advertiser disclosure Global Banking &amp; Finance Review\u00ae is an online platform offering news, analysis, and opinion&hellip;\n","protected":false},"author":2,"featured_media":19385,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[13541,13538,272,13544,13537,13540,13543,13539,13545,13542],"class_list":["post-19384","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-board-shake-up-novo-nordisk","tag-jan-van-de-winkel","tag-novo-nordisk","tag-novo-nordisk-board-2026","tag-novo-nordisk-board-nominations","tag-novo-nordisk-governance","tag-nvo-stock-news","tag-ramona-sequeira","tag-shareholder-meeting-novo-nordisk","tag-wegovy-maker-board"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/19384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=19384"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/19384\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/19385"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=19384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=19384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=19384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}